Please select the option that best describes you:

When would you consider initiation of bempedoic acid for statin intolerant patients (i.e. LDL threshold, comorbidities)?  

How would you assess response to bempedoic acid and its safety on outpatient labs, and how frequently would you have labs monitored?  



Answer from: at Academic Institution
Sign in or Register to read more